|Bid||35.50 x 1000|
|Ask||36.54 x 800|
|Day's Range||33.60 - 36.69|
|52 Week Range||4.14 - 132.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||150.00|
NEW YORK, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Zymergen Inc. (NASDAQ: ZY), Annovis Bio, Inc. (NYSE: ANVS), and Cassava Sciences, Inc. (NASDAQ: SAVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Zymergen Inc. (N
NEW YORK, NY / ACCESSWIRE / September 27, 2021 / Pomerantz LLP announces that a class action lawsuit has been filed against Annovis Bio, Inc. ("Annovis" or the "Company") (NYSE:ANVS) and certain of its officers.
NEW ORLEANS, LA / ACCESSWIRE / September 27, 2021 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C., remind investors of pending deadlines in the following securities class action lawsuits:Annovis Bio, Inc.